[6] Pharmacokinetic Highlights: Oral Bioavailability: 38.4% (rats) [7] Half-Life: ~6.9 hours (oral), ~3.8 hours (IV) in rats Cmax: 2,252 ng/mL (oral, rats) Membrane Permeability: High (passive and active transport) Mechanism of Action 1
Kong W et al. Nat Med. 2004;10(12):1344-51. Yin J et al. Metabolism. 2008;57(5):712-7. Zhang Y et al. J Clin Endocrinol Metab. 2008;93(7):2559-2565. Yang J et al. Evid Based Complement Alternat Med. 2012;2012:363845. Perez-Rubio K et al. Metab Syndr Relat Disord. 2013;11(5):366-9. Cao C et al. Exp Ther Med. 2019;17(4):3009-3014. Lee YS et al. Diabetes. 2006;55:2256-64. Brusq JM et al. J Lipid Res. 2006;47(6):1281-8. Jiang D et al. Lipids Health Dis. 2016;15:214
How BPC-157 Works (Mechanism of Action) BPC-157 is studied in laboratory systems as a signaling pathway modulator that interacts with vascular, cytoskeletal, and cellular stress response pathways
VulliamyTJDUrsoMBattistuzziGEstradaMFoulkesNSMartiniGet alDiverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia
Compound: Body Protection Compound-157 (BPC-157) Concentration: 5mg per vial Format: Lyophilized Powder Chemical Classification: Pentadecapeptide / Gastric Signaling Peptide Chemical Profile: BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acids
RECOMMENDED DOSE: Adults: Take 2 capsules, twice per day with food or as directed by your health care practitioner